“Real-time treatment and monitoring of air quality provides a new tool for infection preventionists to assure the most hygienic care environments are achieved in their facilities.”

Tweet this

June 12, 2018 12:45 PM Eastern Daylight Time

WEST CARROLLTON, Ohio–(BUSINESS WIRE)–Aerobiotix, Inc. will be exhibiting at the Association for Professionals in Infection Control and Epidemiology (APIC) 2018 Annual Conference, June 13-15, 2018 at the Minneapolis Convention Center. Illuvia HUAIRS®, a supplemental air decontamination system for Operating Rooms, will be demonstrated at Booth 1009 as the latest technology in fighting airborne bacteria and contamination in the operating room.

Illuvia HUAIRS® combines a patented ultraviolet energy system and advanced filtration to eliminate airborne pathogens in the occupied hospital environment. This includes drug resistant microbes such as MRSA. “The hardest place to kill a pathogen is inside the human body. If we can eliminate the danger in the air before it gets a chance to enter the patient, the human and economic benefits are huge,” states David Kirschman, M.D., founder of Aerobiotix, Inc. At the APIC conference, Aerobiotix will be introducing the latest version of the Illuvia HUAIRS® system, which includes real-time monitoring and logging of air quality parameters in acute settings. “Real-time treatment and monitoring of air quality provides a new tool for infection preventionists to assure the most hygienic care environments are achieved in their facilities,” states Dr. Kirschman.

Aerobiotix will also be sponsoring a breakfast symposium for APIC attendees, The Next Generation SSI Bundle: Why You Should Consider the Operating Room Environment, which explore the correlation between the environment of the operating room and surgical site infection, with emphasis on the contribution of contaminated air to infections. Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC, will be the speaker, with Sue Barnes, RN, CIC, FAPIC as moderator. The session is Friday, June 15, 6:00-7:45 am, Room 208 A-D Minneapolis Convention Center, and offers a 1.8 CE certificate.


Contact Us


444 Alexandersville Rd
Miamisburg, Ohio 45342

+1 888 978 7087



President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.


Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.


Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.


VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.


Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.


Vice President of Sales

Nathan brings a high level of commitment to servicing and building client relations. He was one of the first employees to start for Aerobiotix. Nathan has previously held leadership roles in the medical device industry. He received his BS from Antioch McGregor University Midwest.


Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.